Emergent BioSolutions Inc. (EBS)
USD 8.16
(-7.17%)
USD 8.16
(-7.17%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -14.85 USD | -232.21% |
| 2022 | -4.47 USD | -209.02% |
| 2021 | 4.10 USD | -29.19% |
| 2020 | 5.79 USD | 446.23% |
| 2019 | 1.06 USD | -15.2% |
| 2018 | 1.25 USD | -36.87% |
| 2017 | 1.98 USD | 53.49% |
| 2016 | 1.29 USD | -20.86% |
| 2015 | 1.63 USD | 66.33% |
| 2014 | 0.98 USD | 13.95% |
| 2013 | 0.86 USD | 32.31% |
| 2012 | 0.65 USD | 0.0% |
| 2011 | 0.65 USD | -60.12% |
| 2010 | 1.63 USD | 59.8% |
| 2009 | 1.02 USD | 47.83% |
| 2008 | 0.69 USD | -12.66% |
| 2007 | 0.79 USD | -20.2% |
| 2006 | 0.99 USD | 28.57% |
| 2005 | 0.77 USD | 26.23% |
| 2004 | 0.61 USD | 154.17% |
| 2003 | 0.24 USD | -87.82% |
| 2002 | 1.97 USD | 6666.67% |
| 2001 | -0.03 USD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -5.38 USD | -3264.71% |
| 2024 Q1 | 0.17 USD | 117.89% |
| 2023 Q4 | -0.95 USD | 81.48% |
| 2023 Q1 | -3.65 USD | -107.39% |
| 2023 Q2 | -5.15 USD | -41.1% |
| 2023 FY | - USD | -232.21% |
| 2023 Q3 | -5.13 USD | 0.39% |
| 2022 Q4 | -1.76 USD | -15.79% |
| 2022 Q2 | -1.13 USD | -1447.95% |
| 2022 Q3 | -1.52 USD | -34.51% |
| 2022 Q1 | -0.07 USD | -102.06% |
| 2022 FY | - USD | -209.02% |
| 2021 Q4 | 3.54 USD | 680.33% |
| 2021 FY | - USD | -29.19% |
| 2021 Q1 | 1.31 USD | -62.68% |
| 2021 Q2 | 0.09 USD | -93.13% |
| 2021 Q3 | -0.61 USD | -777.78% |
| 2020 Q3 | 0.75 USD | -57.39% |
| 2020 Q2 | 1.76 USD | 833.33% |
| 2020 Q1 | -0.24 USD | -126.37% |
| 2020 FY | - USD | 446.23% |
| 2020 Q4 | 3.51 USD | 368.0% |
| 2019 Q3 | 0.84 USD | 566.67% |
| 2019 FY | - USD | -15.2% |
| 2019 Q1 | -0.51 USD | -663.47% |
| 2019 Q2 | -0.18 USD | 64.71% |
| 2019 Q4 | 0.91 USD | 8.33% |
| 2018 Q2 | 1.00 USD | 1100.0% |
| 2018 Q4 | -0.07 USD | -115.9% |
| 2018 FY | - USD | -36.87% |
| 2018 Q1 | -0.10 USD | -112.99% |
| 2018 Q3 | 0.42 USD | -58.0% |
| 2017 Q3 | 0.81 USD | 636.36% |
| 2017 FY | - USD | 53.49% |
| 2017 Q1 | 0.26 USD | -67.5% |
| 2017 Q2 | 0.11 USD | -57.69% |
| 2017 Q4 | 0.77 USD | -4.94% |
| 2016 FY | - USD | -20.86% |
| 2016 Q2 | -0.27 USD | -370.0% |
| 2016 Q4 | 0.80 USD | 53.85% |
| 2016 Q3 | 0.52 USD | 292.59% |
| 2016 Q1 | 0.10 USD | -88.24% |
| 2015 Q4 | 0.85 USD | -9.57% |
| 2015 Q1 | -0.57 USD | -171.25% |
| 2015 FY | - USD | 66.33% |
| 2015 Q2 | 0.37 USD | 164.91% |
| 2015 Q3 | 0.94 USD | 154.05% |
| 2014 Q4 | 0.80 USD | 37.93% |
| 2014 FY | - USD | 13.95% |
| 2014 Q2 | 0.13 USD | 123.64% |
| 2014 Q1 | -0.55 USD | -230.95% |
| 2014 Q3 | 0.58 USD | 346.15% |
| 2013 Q2 | 0.29 USD | 231.82% |
| 2013 Q3 | 0.37 USD | 27.59% |
| 2013 FY | - USD | 32.31% |
| 2013 Q4 | 0.42 USD | 13.51% |
| 2013 Q1 | -0.22 USD | -148.89% |
| 2012 Q1 | -0.19 USD | -123.46% |
| 2012 Q2 | 0.21 USD | 210.53% |
| 2012 Q3 | 0.18 USD | -14.29% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | 0.45 USD | 150.0% |
| 2011 Q1 | -0.61 USD | -175.31% |
| 2011 Q3 | 0.04 USD | -90.0% |
| 2011 Q2 | 0.40 USD | 165.57% |
| 2011 FY | - USD | -60.12% |
| 2011 Q4 | 0.81 USD | 1925.0% |
| 2010 Q1 | 0.08 USD | -38.46% |
| 2010 Q4 | 0.81 USD | 92.86% |
| 2010 FY | - USD | 59.8% |
| 2010 Q3 | 0.42 USD | 31.25% |
| 2010 Q2 | 0.32 USD | 300.0% |
| 2009 Q3 | 0.03 USD | -93.88% |
| 2009 Q2 | 0.49 USD | 32.43% |
| 2009 FY | - USD | 47.83% |
| 2009 Q1 | 0.37 USD | 825.0% |
| 2009 Q4 | 0.13 USD | 333.33% |
| 2008 Q4 | 0.04 USD | -88.57% |
| 2008 Q1 | 0.24 USD | -75.0% |
| 2008 Q2 | 0.06 USD | -75.0% |
| 2008 FY | - USD | -12.66% |
| 2008 Q3 | 0.35 USD | 483.33% |
| 2007 Q1 | -0.10 USD | -108.46% |
| 2007 Q4 | 0.96 USD | 860.0% |
| 2007 Q3 | 0.10 USD | 158.82% |
| 2007 Q2 | -0.17 USD | -76.17% |
| 2007 FY | - USD | -20.2% |
| 2006 Q1 | -0.05 USD | -110.8% |
| 2006 FY | - USD | 28.57% |
| 2006 Q4 | 1.14 USD | 2398.39% |
| 2006 Q3 | -0.05 USD | 0.2% |
| 2006 Q2 | -0.05 USD | 0.0% |
| 2005 Q2 | 0.10 USD | 0.0% |
| 2005 Q3 | 0.10 USD | 0.0% |
| 2005 FY | - USD | 26.23% |
| 2005 Q1 | 0.10 USD | -33.33% |
| 2005 Q4 | 0.46 USD | 360.0% |
| 2004 Q3 | 0.15 USD | 0.0% |
| 2004 Q2 | 0.15 USD | 0.0% |
| 2004 Q4 | 0.15 USD | 0.0% |
| 2004 FY | - USD | 154.17% |
| 2004 Q1 | 0.15 USD | 0.0% |
| 2003 FY | - USD | -87.82% |
| 2002 FY | - USD | 6666.67% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | -1.76 USD | 0.0% |
| 2001 Q3 | - USD | 100.0% |
| 2001 Q2 | -5.15 USD | 0.0% |
| 2001 Q1 | - USD | 100.0% |
| 2000 Q4 | -1.76 USD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | -0.48 USD | -2993.75% |
| Bausch Health Companies Inc. | -1.62 USD | -816.667% |
| Catalent, Inc. | -5.76 USD | -157.813% |
| Elanco Animal Health Incorporated | -2.50 USD | -494.0% |
| Perrigo Company plc | -0.09 USD | -15714.696% |
| Teva Pharmaceutical Industries Limited | -0.50 USD | -2870.0% |
| Zoetis Inc. | 5.08 USD | 392.323% |